Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Expr
Volume degli abstract
Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Expr
Untitled
Untitled
Recent Advances in Numerical Simulations
The role of modelling and computer simulations at various levels of brain organisation
Vaccines | Free Full-Text | Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Express the SARS-CoV-2 Spike Protein
Untitled
Recent Advances in Numerical Simulations
Untitled
Untitled
Thyroid Surgery: Preventing and Managing Complications
The role of modelling and computer simulations at various levels of brain organisation
Recent Advances in Numerical Simulations
HARNESSING DIGITAL TECHNOLOGY FOR CASH TRANSFER PROGRAMMING IN THE EBOLA RESPONSE
Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Expr
Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Expr
Recent Advances in Numerical Simulations
Recent Advances in Numerical Simulations
Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Expr
Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Expr
Vaccines | Free Full-Text | Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Express the SARS-CoV-2 Spike Protein
HARNESSING DIGITAL TECHNOLOGY FOR CASH TRANSFER PROGRAMMING IN THE EBOLA RESPONSE
HARNESSING DIGITAL TECHNOLOGY FOR CASH TRANSFER PROGRAMMING IN THE EBOLA RESPONSE
Select School | ParentSquare
HARNESSING DIGITAL TECHNOLOGY FOR CASH TRANSFER PROGRAMMING IN THE EBOLA RESPONSE
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the E